Pineapple Express Cannabis (PNXP) Cash from Financing Activities (2018 - 2025)

Pineapple Express Cannabis' (PNXP) quarterly Cash from Financing Activities came in at -$1783.0 in Q4 2025, down 514.65% year-on-year from $430.0 in Q4 2024, and up 99.76% quarter-over-quarter from -$746871.0 in Q2 2025.

Pineapple Express Cannabis (PNXP) Cash from Financing Activities (2018 - 2025) Analysis & Trends

Pineapple Express Cannabis has disclosed Cash from Financing Activities across 8 years of filings, most recently posting -$1783.0 for Q4 2025.

  • Cash from Financing Activities for Q4 2025 came in at -$1783.0, down 514.65% year-over-year; the trailing twelve-month figure through Oct 2025 was -$715797.0 (down 2856.13% YoY), and the FY2025 annual result was $45001.0, changed N/A from the prior year.
  • Cash from Financing Activities came in at -$1783.0 for Q4 2025 at Pineapple Express Cannabis, up from -$746871.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $32857.0 in Q1 2025 to a low of -$746871.0 in Q2 2025.
  • The 5-year median for Cash from Financing Activities is $4025.0 (2023), against an average of -$38364.1.
  • Across the five-year window, Cash from Financing Activities surged 9542.98% in 2023 and plunged 6475.88% in 2025, its largest moves.
  • Pineapple Express Cannabis' Cash from Financing Activities stood at $18250.0 in 2021, then sank by 83.02% to $3099.0 in 2022, then sank by 35.46% to $2000.0 in 2023, then tumbled by 78.5% to $430.0 in 2024, then slumped by 514.65% to -$1783.0 in 2025.
  • The last three Cash from Financing Activities figures came in at -$1783.0 (Q4 2025), -$746871.0 (Q2 2025), and $32857.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 Pineapple Express Cannabis - - - -1,783.00

Historic Data

Download Data
DateValue
Oct 31, 2025 -1,783.00
Oct 31, 2025 -1,783.00
Apr 30, 2025 -746,871.00
Apr 30, 2025 -746,871.00
Jan 31, 2025 32,857.00
Jan 31, 2025 32,857.00
Oct 31, 2024 430.00
Oct 31, 2024 430.00
Apr 30, 2024 11,714.00
Apr 30, 2024 11,714.00
Jan 31, 2024 -36,358.00
Jan 31, 2024 -36,358.00
Oct 31, 2023 2,000.00
Oct 31, 2023 2,000.00
Jul 31, 2023 22,661.00
Jul 31, 2023 22,661.00
Apr 30, 2023 11,697.00
Apr 30, 2023 11,697.00
Jan 31, 2023 4,025.00
Jan 31, 2023 4,025.00